Resuscitation Outcomes Consortium

What Is ROC?

ROC Logo

The Resuscitation Outcomes Consortium (ROC) was created to learn which treatments work when people have a cardiac arrest or severe injury. The ROC consists of ten sites and a coordinating center. The ROC investigators work with Emergency Medical Services (EMS) systems and local hospitals at each site to do these studies. Treatments studied include promising resuscitation drugs, tools and techniques.

The ROC Investigators do studies in which people who qualify receive either the currently accepted treatment or a new treatment assigned by chance (that is, in a manner like a coin toss). The trials are designed to test promising new treatments so that EMS providers can use those treatments most likely to benefit the public.

Read the News Article

Further Information:

Current Studies

Amiodarone, Lidocaine, Placebo Study (ALPS)

Enrollment Began June 2012
Read the official NIH Press release.
Read the OHSU Press release.

Learn More about ALPS

Previous Studies

HypoResus

Enrollment Closed April 29, 2013
For more information about the closure of the study, please read the official OHSU press release.

Learn More About This Study

PRIMED

Results were published in the New England Journal of Medicine - September 1, 2011

Visit the PRIMED Study page

Hypertonic Saline Study

10/11/2010- Results published in JAMA.
View the article and results.

Visit the Hypertonic Saline Study page